Vimarsana
Biggest News Aggregation in the World

Page 3 - Interim Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Phase Today - Breaking & Trending Today

AC Immune SA: AC Immune to Present Progress of Alzheimer's Disease Programs targeting Abeta and Tau at the 15th CTAD Conference - Vimarsana News

AC Immune SA: AC Immune to Present Progress of Alzheimer's Disease Programs targeting Abeta and Tau at the 15th CTAD Conference

Next generation SupraAntigen liposomal vaccine platform augments immunization against pathological targets of Alzheimer's diseaseNew data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity

R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing - Vimarsana News

R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting...

Oncolytics Biotech Inc.: Oncolytics Biotech Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting - Vimarsana News

Oncolytics Biotech Inc.: Oncolytics Biotech Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting

Interim results from the phase 1/2 GOBLET study's pancreatic cancer cohort to be presented in a poster on November 11th and discussed during a key opinion leader webinar on November 14th at

Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting - Vimarsana News

Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the acceptance of two abstracts for poster presentations at the Society for...

Shasqi to Present Updated Clinical Data on SQ3370 at the 2022 ASCO Annual Meeting - Vimarsana News

Shasqi to Present Updated Clinical Data on SQ3370 at the 2022 ASCO Annual Meeting

SAN FRANCISCO--(BUSINESS WIRE)--May 31, 2022--

Source: wsiltv.com